T-15-02: Efficacy, safety and consumption of plasma-derived von Willebrand factor (VWF)/Factor VIII (FVIII) concentrate with 2.4:1 VWF:FVIII ratio for the treatment of von Willebrand Disease: a systematic review.
- Resource Type
- Article
- Source
- Hämostaseologie; 2023 Supplement, Vol. 43, pS63-S64, 2p
- Subject
- Language
- ISSN
- 07209355